<p>A: Subgrouped analysis of dosage of PTH (1–34) versus bisphosphonates treatment on spinal BMD. B: Subgrouped analysis of the duration of PTH (1–34) versus bisphosphonates treatment on spinal BMD. ⧫: The study reported BMD data in lateral spine.</p
Aims: To evaluate whether 2 years of treatment with bisphosphonates in combination with calcium/vita...
<p>The figure represents the temporal relationships of percent bone mineral density (BMD) changes fr...
The objective of this study was to estimate the comparative effectiveness of bisphosphonate therapy ...
<p>A: Subgrouped analysis of the dosage of PTH (1–34) versus bisphosphonates treatment on the femora...
<p>A: Subgrouped analysis of the dosage of PTH (1–34) versus bisphosphonates treatment on total hip ...
<p>A: Subgrouped analysis of PTH versus bisphosphonates treatment on BMD of the distal radius in wom...
Bisphosphonates and parathyroid hormone (PTH) represent the antiresorptive and anabolic classes of d...
BACKGROUND: Bisphosphonates and parathyroid hormone (PTH) represent the antiresorptive and anabolic ...
<p>The figure represents the forest plot of percent bone mineral density (BMD) changes from baseline...
<p>Weighted mean difference of percent change of lumbar spine BMD at 6 months (a), 12 months (b), 24...
There has been a conscious effort to address osteoporosis in the aging population. As bisphosphonate...
<p>The figure represents the forest plot of percent bone mineral density (BMD) change from baseline ...
Supplement Figure S5 Forest plot of the BMD changes at three sites at 12 months (subgroup analysis s...
Purpose: This meta-analysis aimed to compare the efficacy and safety of teriparatide vs. bisphosphon...
Background: Ankylosing spondylitis (AS) is not only characterized by excessive bone formation, but a...
Aims: To evaluate whether 2 years of treatment with bisphosphonates in combination with calcium/vita...
<p>The figure represents the temporal relationships of percent bone mineral density (BMD) changes fr...
The objective of this study was to estimate the comparative effectiveness of bisphosphonate therapy ...
<p>A: Subgrouped analysis of the dosage of PTH (1–34) versus bisphosphonates treatment on the femora...
<p>A: Subgrouped analysis of the dosage of PTH (1–34) versus bisphosphonates treatment on total hip ...
<p>A: Subgrouped analysis of PTH versus bisphosphonates treatment on BMD of the distal radius in wom...
Bisphosphonates and parathyroid hormone (PTH) represent the antiresorptive and anabolic classes of d...
BACKGROUND: Bisphosphonates and parathyroid hormone (PTH) represent the antiresorptive and anabolic ...
<p>The figure represents the forest plot of percent bone mineral density (BMD) changes from baseline...
<p>Weighted mean difference of percent change of lumbar spine BMD at 6 months (a), 12 months (b), 24...
There has been a conscious effort to address osteoporosis in the aging population. As bisphosphonate...
<p>The figure represents the forest plot of percent bone mineral density (BMD) change from baseline ...
Supplement Figure S5 Forest plot of the BMD changes at three sites at 12 months (subgroup analysis s...
Purpose: This meta-analysis aimed to compare the efficacy and safety of teriparatide vs. bisphosphon...
Background: Ankylosing spondylitis (AS) is not only characterized by excessive bone formation, but a...
Aims: To evaluate whether 2 years of treatment with bisphosphonates in combination with calcium/vita...
<p>The figure represents the temporal relationships of percent bone mineral density (BMD) changes fr...
The objective of this study was to estimate the comparative effectiveness of bisphosphonate therapy ...